Free Trial

Cyclerion Therapeutics (CYCN) News Today

Cyclerion Therapeutics logo
$2.52 -0.05 (-1.75%)
Closing price 08/29/2025 03:58 PM Eastern
Extended Trading
$2.46 -0.07 (-2.77%)
As of 08/29/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CYCN Latest News

Cyclerion Therapeutics files $25M mixed securities shelf
3 US Penny Stocks With Market Caps Over $10M To Consider
Cyclerion Therapeutics announces update on next stage of growth
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Cyclerion Therapeutics Inc Ordinary Shares CYCN
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 01:04 PM with a stated reason of "LULD pause."...
Cyclerion Therapeutics Inc (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 09:02 AM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 09:12 AM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 10:12 AM with a stated reason of "LULD pause."...
CYCN - Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 02:05 PM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 02:05 PM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 12:05 PM with a stated reason of "LULD pause."...
Cyclerion Therapeutics (Nasdaq:CYCN) Headline
Trading was temporarily halted for "CYCN" at 12:05 PM with a stated reason of "LULD pause."...
Cyclerion Shares Rise After Spurned Bid for Assets
Cyclerion Rejects Unsolicited Proposal To Buy Its Assets
Cyclerion Therapeutics lays off nearly half of workforce
Cyclerion Therapeutics Inc
Get Cyclerion Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYCN Media Mentions By Week

CYCN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYCN
News Sentiment

1.87

1.09

Average
Medical
News Sentiment

CYCN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYCN Articles
This Week

1

0

CYCN Articles
Average Week

Get the Latest News and Ratings for CYCN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CYCN) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners